Paige, ASD is not going after one of CDEx's patents. I don't know what has given you that idea. You seem to think that ASD can't go after CDEX until one of their relevant patents is awarded. That's not the case IMO.
ASD believes that Valimed is infringing on one of their patents, it has no bearing on whether CDEX has been awarded a patent or not.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.